Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Biologic therapies have transformed Crohn's disease management and include several FDA-approved options: TNF- inhibitors : Infliximab (Remicade), adalimumab (Humira), and certolizumab pegol (Cimzia) block tumor necrosis factor-alpha, a key pro-inflammatory cytokine
Screening and identification of DNA aptamers to tyramine using in vitro selection and high-throughput sequencing
Am J Physiol Cell Physiol 2015
Among the seven individuals initially diagnosed with VCD, four (57%) still exhibited the condition during the follow-up appointments, while three showed no further signs of impairment
Lda-Rgo G, Studart-Bott P, Abbade P, Rabelo-Da-Ponte FD, Casqueiro JS, Sarmento S, et al
